Jowell Global posts HY 2025 health and nutritional supplements revenue of USD 42.2 million, up over triple year-on-year

Reuters2025-12-31
Jowell Global posts HY 2025 health and nutritional supplements revenue of USD 42.2 million, up over triple year-on-year

Jowell Global Ltd. reported its unaudited financial results for the first half of 2025. Total revenues for the period were USD 76.2 million, representing a decrease of 11.1 percent. The company’s weighted average unit price was USD 2.59 per unit, a decline of 49.9 percent. Health and nutritional supplements revenue increased by approximately 2.5 times, mainly driven by higher sales of affordable products. The net loss attributable to ordinary shareholders was USD 1.3 million for the first half of 2025. Loss per share was USD 0.58 on a basic and diluted basis. Total comprehensive loss for the period was USD 1.2 million. Weighted average shares outstanding were 2,170,475.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jowell Global Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-126657), on December 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment